Currently, the use of VNS in toxicological contexts is largely experimental. While there is promising research, particularly in the modulation of immune and inflammatory responses, more clinical trials are needed to establish its efficacy and safety in treating toxicological conditions. However, its potential is being actively explored in both preclinical and clinical settings.
